Presentation on theme: "Management of blood glucose and diabetes in critically ill patient receiving enteral feeding. Pamela Charney, et al. Nutrition in Clinical practice."— Presentation transcript:
1Management of blood glucose and diabetes in critically ill patient receiving enteral feeding Pamela Charney, et al. Nutrition in Clinical practice 19: , April 2004.報告者:賴美足
2ˇ1.Mechanics of glucose regulation 2.Evaluation of energy source Management of blood glucose and diabetes in critically ill patient receiving enteral feeding.ˇ1.Mechanics of glucose regulation2.Evaluation of energy source3.Selection of enteral formulas andinfusion routes4.Glycemic control in patients receivingtube feeding
3Insulin The β-cells secrete 40 to 50 units of insulin daily. Endocrine sensors located in the GI tract signal the pancreas.Parenteral nutrition dose not stimulate the early insulin secretion. (∵dextrose bypasses the GI tract)
4Table 1 Metabolic effects of insulin and its action on specific enzymes or proteins Target enzyme or proteinIncrease glucose uptake(muscle)Increase glucose transporter(liver)Increase glucokinaseIncrease glycogen synthesis(liver, muscle)Increase glycogen synthaseDecrease glycogen breakdownDecrease glycogen phosphorylaseIncrease glycolysis, acetyl CoA production (liver, muscle)Increase phosphofructokinase-1Increase fatty acid productionIncrease acetyl CoA carboxylaseIncrease triacylglycerol synthesis(adipose tissue)Increase lipoprotein lipase
5Glucagon The liver is the main site of glucagon action. In the fasting, blood glucose is maintained via hepatic gluconeogenesis and glycogenolysis.Lipolysis and ketogenesis are also stimulated by glucagon.
6Catecholamines epinephrine and norepinephrine Catecholamines epinephrine and norepinephrine act in the periphery to stimulate muscle glycogenolysis.
7During stress or illness, hyperglycemia may cause by: Stress、illness↓Cytokines、Inflammatory mediatorsIncreased gluconeogenesis、Insulin resistancehyperglycemia
81.Mechanics of glucose regulation ˇ2.Evaluation of energy source Management of blood glucose and diabetes in critically ill patient receiving enteral feeding.1.Mechanics of glucose regulationˇ2.Evaluation of energy source3.Selection of enteral formulas andinfusion routes4.Glycemic control in patients receivingtube feeding
9Diet and diabetes: the energy substrate controversy Monounsaturated fatty acidsAlternate carbohydrate sources
10Monounsaturated fatty acids 30% of total calories as MUFA have improvement in lipoprotein and glycemic control in DM patients.High MUFA diet and low GI diet had similar impact on PC glucose in IGT patients.
12Fructose (GI of fructose=19) Small dose (5~10g) : eg, a piece of fruitbeneficial for reducing the acute. postprandial glycemic response. (fig 1.)Large dose (50g) :increase serum TG.malabsorptive diarrhea and intolerance.only small dose had the effect of lower glucose level.
13Figure 1. The effect of fructose on the release of glucokinase from its regulatory protein in the hepatocyte. GKRP, glucokinase regulatory protein.GlucoseFructoseFructokinaseFructose-1-phosphateGlucose-6-phosphateGlucoseInactive glucokinaseActive glucokinaseFructose-6-phosphateFructose-6-phosphateGKRPGKRPNucleusGlycolysisCytosol
14Modifying starch Slowly digested Raw corn starch: cannot be added to liquid formulas. (∵high temp. gelatinization, increase digestibility)OSA-esrerified starch (1-octenyl succinic anhydride-esterified starch): reduced PC glucose. (heat stable, slowly digested)
15FOS (Fructooligosaccharides) Not absorbed from the small intestine no increase in PC glucose.As a prebiotic for healthy bacteria in the large intestine.
16Induced-viscosity complexes Lower glycemia similar to soluble dietary fibers.Outside the body: free-flowing, low-viscosity solutionIn the GI tract: increase viscosity. (∵acid and amylase)Can reduce the tube clogging that occurs with fiber-containing formulas.
17Natural glucose-lowering agents American ginsengOrganic acid (lactic and acetic acids)Fenugreek seedsClausena anisata extract
181.Mechanics of glucose regulation 2.Evaluation of energy source Management of blood glucose and diabetes in critically ill patient receiving enteral feeding.1.Mechanics of glucose regulation2.Evaluation of energy sourceˇ3.Selection of enteral formulas andinfusion routes4.Glycemic control in patients receivingtube feeding
19Enteral formula selection Most “standard” polymeric formulas can be used.For critically ill patients, total calorie may be more importance.Overfeeding should be avoid. (↑insulin requirement)Special formulas specific for DM patients. (↑MUFA, ↓CHO)Most formulas do not contain >15g fiber per liter. (viscosity↑)
21Enteral formula infusion: continuous vs intermittent feeding Continuous feeding allows for improved blood glucose control.Postpyloric feeding be used in patient who have a history of gastroparesis or are at risk for developing delayed gastric emptying.Postpyloric feedings should be initiated on a continuous basis.
221.Mechanics of glucose regulation 2.Evaluation of energy source Management of blood glucose and diabetes in critically ill patient receiving enteral feeding.1.Mechanics of glucose regulation2.Evaluation of energy source3.Selection of enteral formulas andinfusion routesˇ4.Glycemic control in patients receivingtube feeding
23Goals for glycemic control during enteral feeding As close to normal as possible.Hyperglycemia ↑risk of infection.A prospective, randomized, controlled trial comparing standard care vs tight blood glucose control in surgical ICU patients showed that morbidity and mortality were significantly reduced if blood glucose goals were set at 110 mg/dL or lower.Avoidance of hypoglycemia is important.
26Treatment of hypoglycemia in hospitalized adult patients treated with insulin or oral diabetic agentsI. Presumed symptomatic hypoglycemia should be treated without waiting to check plasma or blood glucose level.A. if the patient is able to swallow safely, administer ~15g ofCHO in one of the following forms:1. 5 sugar packets dissolved in 4 ounces (1/2cup) of water.2. 4 ounces (1/2cup) of fruit juice.3. glucose oral gel (glucose 15) 15g orally must be used forthose receiving Acarbose (Precose) or Miglitol (Glyset).B. if the patient has a functioning feeding tube, administer oneof the following by feeding tube:1. 4 ounces (1/2cup) of fruit juice. (not orange juice orother pulp-containing juice)2. 5 sugar packets dissolved in 4 ounces (1/2cup) of water.
27Treatment of hypoglycemia in hospitalized adult patients treated with insulin or oral diabetic agents (續)C. if the patient is not able to take oral feeding or is NPO:1. if IV access is available, administer D50W 25ml (12.5g).2. if no IV access is present, administer Glucagon 1mg bysubcutaneous injection. After glucogen treatment, forthose patients who are not NPO, provide a snack inorder to prevent subsequent hypoglycemia.D. contact either the primary service or the diabetes consulting service, whichever is responsible for the patient’s diabetes management.
28Treatment of hypoglycemia in hospitalized adult patients treated with insulin or oral diabetic agents (續)II. For treatment of asympomatic hypoglycemia (glucose ≦60mg/dl), follow steps A through C above.III. Glucose monitoring after treatment:measure reflectance meter glucose in 15 minutes. If glucose level is not ＞80mg/dl, repeat the treatment outlined above. Recheck the glucose level in 15 minutes. Repeat further treatment (and glucose checks at 15 minutes intervals) until the glucose level is ＞80mg/dl.
29hyperglycemia and hypoglycemia: common causes Illness/infection, Overfeeding, Medications, Insufficient insulin, Volume depletionHypoglycemia:excess insulin dose, severe stress, renal dysfunction, severe hepatitis, sepsis, diabetic gastroparesis
30Glycemic management during enteral feeding Type 1 DM patient: Basal insulin should be provided with CHO, even during periods of no oral intake.Renal dysfunction patients: OHA may be contraindicated in critical.50% of preillness insulin requirements during initiation of feeding.“Sliding scale” + basal insulin
32ConclusionSpecial formulas for DM have not shown improved outcomes when compared with standard formulas.Close monitoring and judicious use of insulin are keys to maintaining control and avoiding complications.
33Reference M. Molly McMahon. Management of parenteral nutrition in acutely ill patients with hyperglycemia.Nutrition in Clinical practice 19: , April 2004.